240
Participants
Start Date
May 25, 2020
Primary Completion Date
August 1, 2020
Study Completion Date
August 30, 2020
Bismuth potassium citrate containing quadruple therapy
Bismuth potassium citrate:given for 14 days at a dose of bismuth potassium citrate 220 mg 0 BID,rabeprazole 10 mg BID, amoxicillin 1000 mg BID, and clarithromycin 500 mg BID
Colloidal pectin bismuth capsules containing quadruple therapy
Bismuth potassium citrate:given for 14 days at a dose of Colloidal pectin bismuth capsules 200 mg 0 BID,rabeprazole 10 mg BID, amoxicillin 1000 mg BID, and clarithromycin 500 mg BID
Colloidal pectin bismuth particles A quadruple therapy
Bismuth potassium citrate:given for 14 days at a dose of Colloidal pectin bismuth particles 150 mg BID,rabeprazole 10 mg BID, amoxicillin 1000 mg BID, and clarithromycin 500 mg BID
Colloidal pectin bismuth particles B quadruple therapy
Bismuth potassium citrate:given for 14 days at a dose of Colloidal pectin bismuth particles 300 mg BID,rabeprazole 10 mg BID, amoxicillin 1000 mg BID, and clarithromycin 500 mg BID
Xijing Hosipital of Digestive Disease, Xi'an
Xijing Hospital of Digestive Diseases
OTHER